Benzinga - Wed, 21 Apr 2021 12:47:38 -0400
Benzinga - Mon, 29 Mar 2021 16:39:09 -0400
Benzinga - Fri, 26 Mar 2021 08:14:31 -0400
Benzinga - Tue, 16 Feb 2021 18:26:48 -0400
Benzinga - Tue, 16 Feb 2021 17:47:07 -0400
Benzinga - Tue, 16 Feb 2021 09:09:51 -0400
Benzinga - Thu, 11 Feb 2021 07:41:10 -0400
Benzinga - Tue, 09 Feb 2021 13:54:24 -0400
load more
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q1 2021Est.ActualSurprise
EPS-0.120
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
OTLKOutlook Therapeutics0.93%376.7M

Outlook Therapeutics Company Questions & Answers

Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) main competitors?

A

Other companies in Outlook Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Jounce Therapeutics (NASDAQ:JNCE) and Adverum Biotechnologies (NASDAQ:ADVM).

Q

What is the target price for Outlook Therapeutics?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on 2020-08-27. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 130.41% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Outlook Therapeutics (OTLK) stock ?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $2.17 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Outlook Therapeutics (OTLK) dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A
Outlook Therapeutics’s Q2 earnings are confirmed after-market from now on May 21, 2021.
Q

When is the upcoming split for OTLK?

A

There is no upcoming split for Outlook Therapeutics.